Sie sind auf Seite 1von 5

1) Review

Management of recurrent cervical cancer: A review of the literature

M. Peirettia, I. Zapardielb, V. Zanagnoloa, F. Landonia, C.P. Morrowc, A.


Maggionia

2). Best Practice & Research Clinical Obstetrics & Gynaecology


Volume 19, Issue 4, August 2005, Pages 631644
Cancer of the Cervix
Management of recurrent cervical cancer

G. Dreyer, MMed, ACOG (Adjunct Professor), L.C. Snyman, MPraxMed,


MMed, FCOG (Senior Consultant), A. Mouton, MPraxMed, MMed, FCOG
(Senior Consultant), B.G. Lindeque, MMed, FCOG, MD , (Professor)

3). Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):249-57.


Recurrent squamous
radiotherapy.

cell

carcinoma

of

cervix

after

definitive

Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Hsueh S.

4) Reports of Practical Oncology & Radiotherapy


Volume 18, Issue 4 , Pages 214-219, July 2013
Correlation between clinical findings and magnetic resonance
imaging for the assessment of local response after standard
treatment in cervical cancer

Izaskun Valduvieco, Albert Biete,


Ivn RiosRicardo Llorente,Angels Rovirosa,
Jaume Pahisa,Laura Vidal,Blanca Farrs,Pilar Samper

5) Local spread of cervical cancer revisited: A clinical and pathological


pattern analysis Original Research Article
Gynecologic Oncology, Volume 117, Issue 3, June 2010, Pages 401-408
Michael Hckel, Thomas Kahn, Jens Einenkel, Norma Manthey, Ulf-Dietrich
Braumann, Guido Hildebrandt, Cornelia Leo, Bettina Hentschel, Peter Vaupel, LarsChristian Horn
6)Patterns of Regional Recurrence After Definitive Radiotherapy for
Cervical Cancer Original Research Article
International Journal of Radiation Oncology*Biology*Physics, Volume 76, Issue 5,
April 2010, Pages 1396-1403
Beth M. Beadle, Anuja Jhingran, Sue S. Yom, Pedro T. Ramirez, Patricia J. Eifel
7) Galectin-1 Is an Independent Prognostic Factor for Local Recurrence and
Survival After Definitive Radiation Therapy for Patients With Squamous
Cell Carcinoma of the Uterine Cervix Original Research Article
International Journal of Radiation Oncology*Biology*Physics, Volume 87, Issue 5, 1
December 2013, Pages 975-982
Eng-Yen Huang, Chan-Chao Chanchien, Hao Lin, Chung-Chi Wang, Chong-Jong Wang,
Chao-Cheng Huang

8) Chemotherapy for advanced or recurrent cervical cancer Review Article


Taiwanese Journal of Obstetrics and Gynecology, Volume 52, Issue 2, June 2013,
Pages 161-164
Toshiharu Kamura, Kimio Ushijima
9) Chemotherapy for recurrent and metastatic cervical cancer Original
Research Article
Gynecologic Oncology, Volume 110, Issue 3, Supplement 2, September 2008, Pages
S67-S71
Xia Tao, Wei Hu, Pedro T. Ramirez, John J. Kavanagh
10) Neoadjuvant chemotherapy prior to pelvic exenteration in patients
with recurrent cervical cancer: Single institution experience Original
Research Article
Gynecologic Oncology, Volume 130, Issue 1, July 2013, Pages 69-74
F. Landoni, V. Zanagnolo, P.G. Rosenberg, A. Lopes, D. Radice, L. Bocciolone, G.
Aletti, G. Parma, N. Colombo, A. Maggioni
11) Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly
Pegylated Liposomal Doxorubicin (Lipo-Dox) Original Research Article
Taiwanese Journal of Obstetrics and Gynecology, Volume 47, Issue 3, September
2008, Pages 322-326
Jen-Ruei Chen, Yuh-Cheng Yang, Tze-Chien Chen, Jerry Cheng-Yen Lai, Shing-Jyh
Chang, Chi-Long Chang, Kung-Liahng Wang

12) Salvage Chemotherapy in Recurrent Cervical Cancer With Biweekly


Pegylated Liposomal Doxorubicin (Lipo-Dox) Original Research Article
Taiwanese Journal of Obstetrics and Gynecology, Volume 47, Issue 3, September
2008, Pages 322-326
Jen-Ruei Chen, Yuh-Cheng Yang, Tze-Chien Chen, Jerry Cheng-Yen Lai, Shing-Jyh
Chang, Chi-Long Chang, Kung-Liahng Wang
13) The activity of carboplatin and paclitaxel for recurrent cervical cancer
after definitive radiotherapy Original Research Article
Gynecologic Oncology, Volume 113, Issue 2, May 2009, Pages 200-204
Seiji Mabuchi, Kenichirou Morishige, Masami Fujita, Tateki Tsutsui, Masahiro Sakata,
Takayuki Enomoto, Tadashi Kimura
14) Multicenter phase II trial of topotecan, cisplatin and bevacizumab for
recurrent or persistent cervical cancer Original Research Article
Gynecologic Oncology, Volume 130, Issue 1, July 2013, Pages 64-68
Israel Zighelboim, Jason D. Wright, Feng Gao, Ashley S. Case, L. Stewart Massad,
David G. Mutch, Matthew A. Powell, Premal H. Thaker, Eric L. Eisenhauer, David E.
Cohn, Fidel A. Valea, Angeles Alvarez Secord, Lynne T. Lippmann, Farrokh Dehdashti,
Janet S. Rader
15Carboplatin and paclitaxel for advanced and recurrent cervical
carcinoma: the British Columbia Cancer Agency experience Original Research
Article
Gynecologic Oncology, Volume 98, Issue 1, July 2005, Pages 54-58
A.V. Tinker, K. Bhagat, K.D. Swenerton, P.J. Hoskins
16) Detection of cervical cancer recurrence during follow-up: A
multivariable comparison of 9 frequently investigated serum biomarkers
Original Research Article
Gynecologic Oncology, Volume 131, Issue 3, December 2013, Pages 655-660
Jacob P. Hoogendam, Afra Zaal, Emma G.G.M. Rutten, Cobi J. Heijnen, Gemma G.
Kenter, Wouter B. Veldhuis, Ren H.M. Verheijen, Ronald P. Zweemer
17) A multi-institutional phase II trial of paclitaxel and carboplatin in the
treatment of advanced or recurrent cervical cancer Original Research Article
Gynecologic Oncology, Volume 125, Issue 2, May 2012, Pages 307-311
Ryo Kitagawa, Noriyuki Katsumata, Masashi Ando, Chikako Shimizu, Yasuhiro
Fujiwara, Hiroyuki Yoshikawa, Toyomi Satoh, Toru Nakanishi, Kimio Ushijima,
Toshiharu Kamura
18) Are supportive care-based treatment strategies preferable to standard
chemotherapy in recurrent cervical cancer? Original Research Article
Gynecologic Oncology, Volume 130, Issue 2, August 2013, Pages 317-322
Neil T. Phippen, Charles A. Leath III, Caela R. Miller, William J. Lowery, Laura J.
Havrilesky, Jason C. Barnett
19) Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A
New York Cancer Consortium Study Original Research Article
Gynecologic Oncology, Volume 116, Issue 3, March 2010, Pages 442-446

Dennis Yi-Shin Kuo, Stephanie V. Blank, Paul J. Christos, Mimi Kim, Thomas A.
Caputo, Bhavana Pothuri, Dawn Hershman, Noah Goldman, Percy S. Ivy, Carolyn D.
Runowicz, Franco Muggia, Gary L. Goldberg, Mark H. Einstein
20) Intraoperative Electron Beam Radiation Therapy (IOERT) in the
Management of Locally Advanced or Recurrent Cervical Cancer
International Journal of Radiation Oncology*Biology*Physics, Volume 84, Issue 3,
Supplement, 1 November 2012, Page S426
B.M. Barney, I.A. Petersen, M.G. Haddock
21Molecular imaging in the management of cervical cancer Review Article
Journal of the Formosan Medical Association, Volume 111, Issue 8, August 2012,
Pages 412-420
Chyong-Huey Lai, Tzu-Chen Yen, Koon-Kwan Ng
22Invasive cancer of the cervix Original Research Article
Obstetrics, Gynaecology & Reproductive Medicine, Volume 17, Issue 6, June 2007,
Pages 181-187
Bryony Simcock, Mahmood Shaf)
23CON: Patients With Metastatic/Recurrent Cervical Cancer Should Not Be
Treated With Cisplatin Plus Paclitaxel Original Research Article
Clinical Ovarian Cancer, Volume 3, Issue 1, May 2010, Pages 18-20
J. Tate Thigpen)
24) Anti-angiogenesis agents in metastatic or recurrent cervical cancer
Review Article
Gynecologic Oncology, Volume 116, Issue 2, February 2010, Pages 181-186
Bradley J. Monk, Lyndsay J. Willmott, Daniele A. Sumner
25) Chemotherapy for recurrent cervical cancer Original Research Article
Gynecologic Oncology, Volume 107, Issue 1, Supplement, October 2007, Pages
S113-S118
Isabelle Cadron, Toon Van Gorp, Frederic Amant, Karin Leunen, Patrick Neven,
Ignace Vergote
26A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced
and recurrent cervical cancer Original Research Article
Gynecologic Oncology, Volume 95, Issue 2, November 2004, Pages 347-351
Levi S. Downs Jr., Patricia L. Judson, Peter A. Argenta, Linda F. Carson, Matthew P.
Boente
27Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant
treatment in locally advanced cervical cancer: Long-term results Original
Research Article
Gynecologic Oncology, Volume 128, Issue 3, March 2013, Pages 518-523
G. Ferrandina, M.G. Distefano, R. De Vincenzo, V. Salutari, M. Petrillo, M.L. Scarciglia,
A. Pietragalla, C. Conte, G. Scambia)

28. Weekly Carboplatin and Docetaxel for Locally Advanced Primary and
Recurrent Cervical Cancer: A Phase I Study Original Research Article
Gynecologic Oncology, Volume 87, Issue 1, October 2002, Pages 98-103
D.T. Rein, C.M. Kurbacher, M. Breidenbach, T. Schndorf, T. Schmidt, E. Knig, U.-J.
Ghring, J.-U. Blohmer, P. Mallmann
29. Biochemical prognostic factors and risk of relapses in patients with
cervical cancer
Gynecologic Oncology, Volume 107, Issue 1, Supplement, October 2007, Pages S23S26
Angiolo Gadducci, Roberta Tana, Antonio Fanucchi, Andrea Riccardo Genazzani

Das könnte Ihnen auch gefallen